Drug
Isavuconazole clinical trials
Also written BAL8557, BAL4815, Cresemba and Isavuconazonium sulfate.
- studies test it
- 38
- open now
- 1
- in phase 3
- 6
- first study started
- 2006
Keep track of what changes. Save the isavuconazole studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
Other names
Studies by the year they started
38 studies that test it; most in 2012 (15)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2011 | 4 |
| 2012 | 15 |
| 2013 | 3 |
| 2014 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 27
- Phase 2
- 4
- Phase 3
- 6
- Phase 4
- 1
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 34 · Other 4
Astellas Pharma Global Development, Inc. (23) · Astellas Pharma Inc (7) · Pfizer (1) · Memorial Sloan Kettering Cancer Center (1) · Basilea Pharmaceutica (1) · Acerta Pharma BV (1) · M.D. Anderson Cancer Center (1) · Asahi Kasei Pharma Corporation (1)
Often tested with
Tested in the same studies.
Fluconazole (1) · Bupropion (1) · Digoxin (1) · Ketoconazole (1) · Atorvastatin (1) · Dextromethorphan (1) · Lopinavir-ritonavir drug combination (1) · Repaglinide (1)
Studies
Open first, then newest update. How each study uses isavuconazole is read from its arms, and is right about nine times in ten.
Testing it · 38
- Study on Theraputic Drug Monitoring and Phamacokinetics of Isavuconazole in ChildrenRecruitingNot applicableShanghai Children's Medical CenterNCT06440915Written as Isavuconazole
- Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous FungiCompletedPhase 4PfizerNCT05630976Written as Isavuconazole
- Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)CompletedPhase 2Memorial Sloan Kettering Cancer CenterNCT03149055Written as Isavuconazole
- Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare FungiCompletedPhase 3Astellas Pharma IncNCT00634049Written as isavuconazole
- Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida InfectionsCompletedPhase 3Astellas Pharma IncNCT00413218Written as Isavuconazole
- Isavuconazole (BAL8557) for Primary Treatment of Invasive AspergillosisCompletedPhase 3Astellas Pharma IncNCT00412893Written as Isavuconazole
- A Study to Evaluate Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric ParticipantsCompletedPhase 2Astellas Pharma Global Development, Inc.NCT03816176Written as Isavuconazonium sulfate
- A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy ParticipantsCompletedPhase 1Astellas Pharma Global Development, Inc.NCT04096157Written as Isavuconazonium sulfate IV
- A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric PatientsCompletedPhase 1Astellas Pharma Global Development, Inc.NCT03241550Written as isavuconazonium sulfate - intravenous
- Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing ChemotherapyCompletedPhase 2/3Basilea PharmaceuticaNCT00413439Written as Isavuconazole
- Isavuconazole for the Prevention of COVID-19-associated Pulmonary AspergillosisTerminatedPhase 3Jeffrey Jenks, MD, MPHNCT04707703Written as Isavuconazonium Injection [Cresemba]
- A Study to Evaluate the Effect of Pharmacokinetics (PK) of Acalabrutinib and Its Active Metabolite (ACP-5862) When Administered Alone and With Moderate CYP3A4 Inhibitors Fluconazole or Isavuconazole in Healthy Adult ParticipantsCompletedPhase 1Acerta Pharma BVNCT05140096Written as Isavuconazole
- Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and NeutropeniaCompletedPhase 2M.D. Anderson Cancer CenterNCT03019939Written as Isavuconazole
- Clinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep MycosisCompletedPhase 3Asahi Kasei Pharma CorporationNCT03471988Written as AK1820
- Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole.CompletedPhase 1Astellas Pharma Global Development, Inc.NCT01555866Written as isavuconazole
- Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of BupropionCompletedPhase 1Astellas Pharma Global Development, Inc.NCT01635972Written as Isavuconazole
- Drug Interaction Study of Isavuconazole and DigoxinCompletedPhase 1Astellas Pharma Global Development, Inc.NCT01582412Written as Isavuconazole
- Drug Interaction Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose of Isavuconazole in Healthy Adult SubjectsCompletedPhase 1Astellas Pharma Global Development, Inc.NCT01657838Written as Isavuconazole
- Study of the Pharmacokinetics of Isavuconazole in Healthy Non-Elderly and Elderly Male and Female SubjectsCompletedPhase 1Astellas Pharma Global Development, Inc.NCT01657890Written as isavuconazole
- Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of AtorvastatinCompletedPhase 1Astellas Pharma Global Development, Inc.NCT01635946Written as Isavuconazole
See all 38 studies that test isavuconazole →
Given in every arm · 3 — isavuconazole is usual care beside what is tested
- Study of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic SyndromeNot yet recruitingPhase 1M.D. Anderson Cancer CenterNCT07780565Written as Isavuconazole
- Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS)Active, not recruitingPhase 2National Cancer Institute (NCI)NCT03964090Written as Isavuconazole
- Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS LymphomaActive, not recruitingPhase 1National Cancer Institute (NCI)NCT02203526Written as Isavuconazole
Codes
What other systems call isavuconazole · ClinicalTrials.gg INT004880
- MeSH (NLM) C508735isavuconazoleConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 60UTO373KEISAVUCONAZOLEConfirmed FDA, NLM, Wikidata
- RxNorm 1720882Confirmed FDA, Wikidata
- Wikidata Q6079042isavuconazoleConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C64543IsavuconazoleOne source FDA
- DrugBank DB11633One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C508735 | isavuconazole | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 60UTO373KE | ISAVUCONAZOLE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1720882 | — | Confirmed FDA, Wikidata |
| Wikidata | Q6079042 | isavuconazole | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C64543 | Isavuconazole | One source FDA |
| DrugBank | DB11633 | — | One source Wikidata |
Also registered as isavuconazonium (UNII VH2L779W8Q · RxNorm 1608322) and isavuconazonium sulfate (UNII 31Q44514JV · RxNorm 1608321).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.